[HTML][HTML] Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China

X Meng, C Guo, G Feng, Y Zhao, B Zhou… - Acta Pharmacologica …, 2012 - nature.com
Aim: To evaluate retrospectively the association of cytochrome P450 3A (CYP3A) and ATP-
binding cassette sub-family B member 1 (ABCB1) gene polymorphisms with the …

[HTML][HTML] Effect of CYP3A4, CYP3A5, MDR1 and POR Genetic Polymorphisms in Immunosuppressive Treatment in Chilean Kidney Transplanted Patients

S Contreras-Castillo, A Plaza, J Stojanova… - Frontiers in …, 2021 - frontiersin.org
Cyclosporine (CsA) and tacrolimus (TAC) are immunosuppressant drugs characterized by a
narrow therapeutic range and high pharmacokinetic variability. The effect of polymorphisms …

Multi‐drug resistance gene‐1 (MDR‐1) haplotypes and the CYP3A5*1 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 …

S Fredericks, AM Jorga, IAM MacPhee… - Clinical …, 2007 - Wiley Online Library
The intestinal efflux pump P‐glycoprotein (P‐gp), the product of the multi‐drug resistance‐1
(MDR‐1) gene, significantly influences the pharmacokinetics of several drugs. Ciclosporin is …

The effect of CYP3A5 polymorphism on dose-adjusted cyclosporine concentration in renal transplant recipients: a meta-analysis

HJ Zhu, SH Yuan, Y Fang, XZ Sun, H Kong… - The pharmacogenomics …, 2011 - nature.com
Cyclosporine (CsA) is a substrate of cytochrome P450 (CYP) 3A5 and has a narrow
therapeutic range with large inter-individual variability. CYP3A5* 3 polymorphism is reported …

Influence of CYP3A and MDR1 genetic polymorphisms on the pharmacokinetics of ciclosporin A

YF XU - Journal of International Pharmaceutical Research, 2015 - pesquisa.bvsalud.org
Ciclosporin A (CsA). an immunosuppressive macrolide antibiotics, is widely applied to
prevent rejections after organ transplants. CsA is mainly transported by P-glycoprotein (P …

Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients

O Sharaki, M Zeid, P Moez, NH Zakaria… - Molecular biology …, 2015 - Springer
Advances in immunosuppressive therapy allowed renal transplantation to become the
treatment of choice for suitable candidates with (end stage renal disease) ESRD. The post …

Influence of the MDR1 haplotype and CYP3A5 genotypes on cyclosporine blood level in Chinese renal transplant recipients

B Chen, W Zhang, J Fang, Z Jin, J Li, Z Yu, W Cai - Xenobiotica, 2009 - Taylor & Francis
The purpose of the study was to elucidate the influence of multidrug resistance gene
(MDR1) haplotype and CYP3A5 genotype on cyclosporine (CsA) blood level in Chinese …

Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated …

Y Wang, C Wang, J Li, X Wang, G Zhu, X Chen… - European journal of …, 2009 - Springer
Objective The aim of this study was to assess the influence of the cytochrome (CYP450) 3A5
and multidrug resistance (MDR1) gene polymorphisms on cyclosporine A (CsA) trough …

Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR‐1 …

DA Hesselink, T van Gelder… - Clinical …, 2004 - Wiley Online Library
Objective Our objective was to determine the relationship between single nucleotide
polymorphisms (SNPs) in the multidrug resistance 1 (MDR‐1) gene and the cytochrome …

Polymorphisms of multidrug resistance gene (MDR1) and cyclosporine absorption in de novo renal transplant patients

CJ Foote, W Greer, B Kiberd, A Fraser, J Lawen… - …, 2007 - journals.lww.com
Background. Several single nucleotide polymorphisms (SNPs) in the multidrug resistance
(MDR1) gene may play a role in the interindividual variation of cyclosporine A (CsA) …